Sang-We Kim
0000-0003-1065-8095
1 paper found
Refreshing results…
Osimertinib + Savolitinib to Overcome Acquired MET-Mediated Resistance in Epidermal Growth Factor Receptor–Mutated, MET-Amplified Non–Small Cell Lung Cancer: TATTON
Missing publications? Search for publications with a matching author name.